The world health organization (who) has suspended trials of hydroxychloroquine as a possible drug for the treatment of coronavirus infection, said at a briefing on may 25, the who Director-General tedros adhanom Ghebreyesus.
“The Executive group has introduced a temporary pause to the test of hydroxychloroquine in the study, “Solidarity”, – quotes the press service of the organization.
Testing will be suspended until then, until the Committee on data and safety monitoring of research subjects will not analyze data on the drug, said Ghebreyesus.
Now, the study “Solidarity”, as reported on the website of the organization involved nearly 1,700 patients in 17 countries.
Hydroxychloroquine used in malaria, lupus, rheumatoid arthritis, tested in some countries for the treatment of coronavirus infection. Some researchers have pointed to its effectiveness, but, according to others, it can cause serious adverse reactions, including disruption of the cardiovascular system. The American Management on sanitary inspection behind quality of foodstuff and medicines (FDA) warned the use of hydroxychloroquine or chloroquine for the treatment of coronavirus infection outside medical institutions because of risk of irregular heart rhythm.
Of ghebreyesus stressed that hydroxychloroquine and chloroquine are considered safe for patients with autoimmune diseases and malaria.
On may 26 who said that the organization expects the conclusions of the Committee on the monitoring data in June.
“The final decision about the harm, the use or lack of use of hydroxychloroquine will be taken only after analyzing all the data. This is expected to be in mid – June,” – said in a statement.
Who took the decision to suspend the trials of hydroxychloroquine after that article about its effectiveness in the British medical journal The Lancet. The researchers came to the conclusion that the drug may increase the risk of death from coronavirus.
The President of the United States Donald trump within two weeks took hydroxychloroquine for the prevention of coronavirus disease.
Special medications from coronavirus infection COVID-19 does not exist now in this disease is only symptomatic treatment. The who notedthat a number of medicines can contribute to improved well-being and relief of symptoms COVID-19, but there is no evidence that any drug to prevent or treat the disease.
Hydroxychloroquine in the treatment COVID-19 is used in Ukraine, reported the Ministry of health.